New CB1R agonist-positive allosteric modulators with improved drug-like physicochemical properties March 4, 2020
Biogen and Sangamo Therapeutics announce licensing collaboration agreement in neurology March 2, 2020
Enrollment completed in phase Ib study of NF-kB decoy for chronic discogenic lumbar back pain March 2, 2020
RSS